Product Code: VMR11214085
The Amniotic Membrane Market size is expected to reach USD 16.73 Billion in 2034 from USD 5.36 Billion (2025) growing at a CAGR of 13.49% during 2026-2034.
The global amniotic membrane market has grown due to its increasing use in regenerative medicine and wound healing treatments. Amniotic membranes, derived from the inner lining of the placenta, contain growth factors and biological components that promote tissue repair. These membranes are widely used in ophthalmology, dermatology, and surgical procedures to support healing and reduce inflammation.
Several factors are driving the market's expansion. The rising demand for advanced wound care treatments and regenerative therapies has increased the use of amniotic membrane products. Healthcare providers are using these materials in treatments for chronic wounds, burns, and eye surface disorders. Advances in tissue preservation and processing technologies have also improved the safety and effectiveness of amniotic membrane products.
The future outlook for the amniotic membrane market remains strong as regenerative medicine continues to advance. Research is exploring new medical applications for these biological materials in orthopedic and reconstructive procedures. Increasing healthcare investments and expanding medical research may create additional opportunities. As interest in biologically based therapies grows, the demand for amniotic membrane products is expected to increase.
MARKET SEGMENTATION
By Product
- Cryopreserved Amniotic Membrane
- Dehydrated Amniotic Membrane
By Application
- Surgical Wounds
- Ophthalmology
- Others
By End Use
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research Institutes and Academic Institutes
COMPANIES PROFILED
- Alliqua BioMedical Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, DermaSciences, Katena Products Inc, MiMedx Group Inc, Skye Biologics Inc, Amniox Medical Inc, Organogensis Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL AMNIOTIC MEMBRANE MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Cryopreserved Amniotic Membrane Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Dehydrated Amniotic Membrane Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL AMNIOTIC MEMBRANE MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Surgical Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL AMNIOTIC MEMBRANE MARKET: BY END USE 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End Use
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Research Institutes and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL AMNIOTIC MEMBRANE MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product
- 7.2.2 By Application
- 7.2.3 By End Use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product
- 7.3.2 By Application
- 7.3.3 By End Use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product
- 7.4.2 By Application
- 7.4.3 By End Use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product
- 7.5.2 By Application
- 7.5.3 By End Use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product
- 7.6.2 By Application
- 7.6.3 By End Use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL AMNIOTIC MEMBRANE INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Alliqua BioMedical Inc
- 9.2.2 Amnio Technology LLC
- 9.2.3 Applied Biologics LLC
- 9.2.4 Human Regenerative Technologies LLC
- 9.2.5 DermaSciences
- 9.2.6 Katena Products Inc
- 9.2.7 MiMedx Group Inc
- 9.2.8 Skye Biologics Inc
- 9.2.9 Amniox Medical Inc
- 9.2.10 Organogensis Inc